| scholarly article | Q13442814 |
| P2093 | author name string | H Xiao | |
| K T Jeang | |||
| H L Tiffany | |||
| P M Murphy | |||
| M Benkirane | |||
| E A Rich | |||
| C Neuveut | |||
| P2860 | cites work | CXCR4 expression during lymphopoiesis: implications for human immunodeficiency virus type 1 infection of the thymus | Q35892412 |
| Tat as one key to HIV-induced immune pathogenesis and Tat (correction of Pat) toxoid as an important component of a vaccine | Q35993736 | ||
| Change in coreceptor use correlates with disease progression in HIV-1--infected individuals | Q36376800 | ||
| The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection | Q38949380 | ||
| Extracellular HIV-1 tat protein up-regulates the expression of surface CXC-chemokine receptor 4 in resting CD4+ T cells. | Q39443021 | ||
| CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: delineation of consensus motif in the V3 domain that predicts CCR-5 usage. | Q39607422 | ||
| Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex | Q40128160 | ||
| Indicator cell lines for detection of primary strains of human and simian immunodeficiency viruses | Q41104028 | ||
| Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. | Q41335848 | ||
| Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients | Q41734588 | ||
| Macrophage inflammatory protein-1beta induces migration and activation of human thymocytes. | Q42830305 | ||
| Similarity of chemokines charge and the V3 domain of HIV-1 env protein | Q43183430 | ||
| CXCR4 and CCR5 expression delineates targets for HIV-1 disruption of T cell differentiation. | Q52532093 | ||
| Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. | Q53421778 | ||
| Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine | Q59511395 | ||
| The neglected role of type I interferon in the T-cell response: implications for its clinical use | Q71475326 | ||
| Transplantation of discordant xenografts: a challenge revisited | Q71475332 | ||
| HIV-1 entry inhibitors: evading the issue | Q95817407 | ||
| Genotypic and phenotypic characterization of HIV-1 patients with primary infection | Q22242245 | ||
| HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor | Q22242268 | ||
| Identification of a major co-receptor for primary isolates of HIV-1 | Q22251282 | ||
| A new classification for HIV-1 | Q22251292 | ||
| Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 Tat | Q22253931 | ||
| Cloning and functional expression of CC CKR5, a human monocyte CC chemokine receptor selective for MIP-1(alpha), MIP-1(beta), and RANTES | Q24310697 | ||
| Identification of CCR8: a human monocyte and thymus receptor for the CC chemokine I-309 | Q24653253 | ||
| A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors | Q28118386 | ||
| Epithelin/granulin growth factors: extracellular cofactors for HIV-1 and HIV-2 Tat proteins | Q28138821 | ||
| Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells | Q28270680 | ||
| The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates | Q28282895 | ||
| Activity of different bicyclam derivatives against human immunodeficiency virus depends on their interaction with the CXCR4 chemokine receptor | Q28293420 | ||
| Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4 | Q28379182 | ||
| A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection | Q28379184 | ||
| A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor | Q28379187 | ||
| The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression | Q28507706 | ||
| CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1 | Q28646859 | ||
| HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time | Q29547822 | ||
| HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 | Q29616094 | ||
| Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease | Q29616432 | ||
| Conditional reduction of human immunodeficiency virus type 1 replication by a gain-of-herpes simplex virus 1 thymidine kinase function | Q30424775 | ||
| Multifaceted activities of the HIV-1 transactivator of transcription, Tat. | Q33743566 | ||
| Analysis of the temporal relationship between human immunodeficiency virus type 1 quasispecies in sequential blood samples and various organs obtained at autopsy | Q33782045 | ||
| CXCR-4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of human immunodeficiency virus type 1 | Q33782165 | ||
| Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains | Q33785321 | ||
| Angiogenic properties of human immunodeficiency virus type 1 Tat protein | Q34267637 | ||
| Vaccination with tat toxoid attenuates disease in simian/HIV-challenged macaques | Q35114827 | ||
| Pronounced acute immunosuppression in vivo mediated by HIV Tat challenge | Q35633540 | ||
| Recombinant human immunodeficiency virus type 1 genomes with tat unconstrained by overlapping reading frames reveal residues in Tat important for replication in tissue culture. | Q35866513 | ||
| Mapping of independent V3 envelope determinants of human immunodeficiency virus type 1 macrophage tropism and syncytium formation in lymphocytes. | Q35874433 | ||
| Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry | Q35880381 | ||
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | HIV | Q15787 |
| P304 | page(s) | 11466-71 | |
| P577 | publication date | 2000-10-10 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1 | |
| P478 | volume | 97 |
| Q46698274 | "cART intensification by the HIV-1 Tat B clade vaccine: progress to phase III efficacy studies". |
| Q37054470 | A HIV-Tat/C4-binding protein chimera encoded by a DNA vaccine is highly immunogenic and contains acute EcoHIV infection in mice |
| Q33931214 | A cell-penetrating antibody fragment against HIV-1 Rev has high antiviral activity: characterization of the paratope |
| Q34666037 | Activation of Egr-1 expression in astrocytes by HIV-1 Tat: new insights into astrocyte-mediated Tat neurotoxicity |
| Q92906228 | Anti-Tat Immunity in HIV-1 Infection: Effects of Naturally Occurring and Vaccine-Induced Antibodies Against Tat on the Course of the Disease |
| Q73138904 | Antibodies to Tat and Vpr in the GRIV cohort: differential association with maintenance of long-term non-progression status in HIV-1 infection |
| Q30410538 | Anxiety-like behavior of mice produced by conditional central expression of the HIV-1 regulatory protein, Tat. |
| Q55315393 | Apolipoprotein E isoform dependently affects Tat-mediated HIV-1 LTR transactivation. |
| Q35114694 | Breaking down the barrier: the effects of HIV-1 on the blood-brain barrier. |
| Q42255378 | Breaking in and busting out: cell-penetrating peptides and the endosomal escape problem. |
| Q36599919 | CD44-mediated monocyte transmigration across Cryptococcus neoformans-infected brain microvascular endothelial cells is enhanced by HIV-1 gp41-I90 ectodomain |
| Q41930612 | Canonical and Non-Canonical Autophagy in HIV-1 Replication Cycle |
| Q39955713 | Caveolin-1 regulates human immunodeficiency virus-1 Tat-induced alterations of tight junction protein expression via modulation of the Ras signaling |
| Q35126422 | Changing patterns in the neuropathogenesis of HIV during the HAART era. |
| Q40720095 | Characterization of the anti-HIV effects of native lactoferrin and other milk proteins and protein-derived peptides |
| Q35050395 | Chemokine receptors: emerging opportunities for new anti-HIV therapies |
| Q35198110 | Chemokines and viruses: friends or foes? |
| Q35945472 | Cocaine self-administration enhances excitatory responses of pyramidal neurons in the rat medial prefrontal cortex to human immunodeficiency virus-1 Tat. |
| Q37348901 | Codon optimization of the tat antigen of human immunodeficiency virus type 1 generates strong immune responses in mice following genetic immunization |
| Q27013928 | Cortical consequences of HIV-1 Tat exposure in rats are enhanced by chronic cocaine |
| Q55365547 | Cyclophilin A enables specific HIV-1 Tat palmitoylation and accumulation in uninfected cells. |
| Q40182651 | D1/NMDA receptors and concurrent methamphetamine+ HIV-1 Tat neurotoxicity |
| Q61799358 | Didehydro-Cortistatin A Inhibits HIV-1 by Specifically Binding to the Unstructured Basic Region of Tat |
| Q35559749 | Didehydro-cortistatin A inhibits HIV-1 Tat mediated neuroinflammation and prevents potentiation of cocaine reward in Tat transgenic mice |
| Q33897742 | Differential induction of interleukin-10 in monocytes by HIV-1 clade B and clade C Tat proteins. |
| Q35003533 | Differential induction of rat neuronal excitotoxic cell death by human immunodeficiency virus type 1 clade B and C tat proteins. |
| Q34017924 | Direct effects of HIV-1 Tat on excitability and survival of primary dorsal root ganglion neurons: possible contribution to HIV-1-associated pain |
| Q47397529 | Doxycycline-inducible and astrocyte-specific HIV-1 Tat transgenic mice (iTat) as an HIV/neuroAIDS model. |
| Q36445102 | Dual role of autophagy in HIV-1 replication and pathogenesis |
| Q42683735 | Dynamic plasticity of NMDA receptor-mediated calcium entry in neurons exposed to HIV-tat. |
| Q41620362 | E5564 inhibits immunosuppressive cytokine IL-10 induction promoted by HIV-1 Tat protein |
| Q40052643 | Effects of HIV-1 Tat and Methamphetamine on Blood-Brain Barrier Integrity and Function In Vitro |
| Q36997333 | Endolysosome involvement in HIV-1 transactivator protein-induced neuronal amyloid beta production |
| Q36563605 | Endothelial cells and cathepsins: Biochemical and biomechanical regulation |
| Q59360928 | Epigenetic Promoter DNA Methylation of miR-124 Promotes HIV-1 Tat-Mediated Microglial Activation via MECP2-STAT3 Axis |
| Q34517239 | Excess soluble CD40L contributes to blood brain barrier permeability in vivo: implications for HIV-associated neurocognitive disorders |
| Q40676905 | Exosome-associated release, uptake, and neurotoxicity of HIV-1 Tat protein. |
| Q37988482 | Exploring transduction mechanisms of protein transduction domains (PTDs) in living cells utilizing single-quantum dot tracking (SQT) technology |
| Q39616924 | Expressed cell-penetrating peptides can induce a bystander effect, but passage through the secretory pathway reduces protein transduction activity. |
| Q38790617 | Fate of microglia during HIV-1 infection: From activation to senescence? |
| Q38617624 | Functional roles of HIV-1 Tat protein in the nucleus. |
| Q24795458 | Gene expression profile of HIV-1 Tat expressing cells: a close interplay between proliferative and differentiation signals |
| Q37010956 | Generation and characterization of neutralizing human monoclonal antibodies against human immunodeficiency virus type 1 Tat antigen |
| Q33819189 | Genetic variation and HIV-associated neurologic disease. |
| Q92135927 | Genetic variation and function of the HIV-1 Tat protein |
| Q36242915 | HIV Infects Bronchial Epithelium and Suppresses Components of the Mucociliary Clearance Apparatus |
| Q37490454 | HIV Tat Impairs Neurogenesis through Functioning As a Notch Ligand and Activation of Notch Signaling Pathway |
| Q40271342 | HIV Tat induces a prolonged MYC relocalization next to IGH in circulating B-cells. |
| Q39494342 | HIV Tat protein inhibits hERG K+ channels: a potential mechanism of HIV infection induced LQTs |
| Q35088029 | HIV Tat, its TARgets and the control of viral gene expression |
| Q36675927 | HIV Tat-Mediated Induction of Human Brain Microvascular Endothelial Cell Apoptosis Involves Endoplasmic Reticulum Stress and Mitochondrial Dysfunction. |
| Q39641516 | HIV Type 1 Nef is released from infected cells in CD45(+) microvesicles and is present in the plasma of HIV-infected individuals |
| Q38824376 | HIV and viral protein effects on the blood brain barrier |
| Q59361093 | HIV-1 Protein Tat Impairs Neuronal Dendrites via Activation of PP1 and Regulation of the CREB/BDNF Pathway |
| Q59357751 | HIV-1 TAT-mediated microglial activation: role of mitochondrial dysfunction and defective mitophagy |
| Q95326529 | HIV-1 Tat - TLR4/MD2 interaction drives the expression of IDO-1 in monocytes derived dendritic cells through NF-κB dependent pathway |
| Q27487322 | HIV-1 Tat Activates Neuronal Ryanodine Receptors with Rapid Induction of the Unfolded Protein Response and Mitochondrial Hyperpolarization |
| Q38963813 | HIV-1 Tat C modulates NOX2 and NOX4 expressions through miR-17 in a human microglial cell line |
| Q43598814 | HIV-1 Tat C modulates expression of miRNA-101 to suppress VE-cadherin in human brain microvascular endothelial cells. |
| Q37002574 | HIV-1 Tat Protein Activates both the MyD88 and TRIF Pathways To Induce Tumor Necrosis Factor Alpha and Interleukin-10 in Human Monocytes. |
| Q35668299 | HIV-1 Tat Protein Induces Production of Proinflammatory Cytokines by Human Dendritic Cells and Monocytes/Macrophages through Engagement of TLR4-MD2-CD14 Complex and Activation of NF-κB Pathway. |
| Q37176830 | HIV-1 Tat Regulates Occludin and Aβ Transfer Receptor Expression in Brain Endothelial Cells via Rho/ROCK Signaling Pathway |
| Q24564896 | HIV-1 Tat enters T cells using coated pits before translocating from acidified endosomes and eliciting biological responses |
| Q41505540 | HIV-1 Tat inhibits phagocytosis by preventing the recruitment of Cdc42 to the phagocytic cup. |
| Q34508575 | HIV-1 Tat protein binds to TLR4-MD2 and signals to induce TNF-α and IL-10. |
| Q34758981 | HIV-1 Tat protein increases microglial outward K(+) current and resultant neurotoxic activity |
| Q46245165 | HIV-1 Tat protein induces DNA damage in human peripheral blood B-lymphocytes via mitochondrial ROS production. |
| Q40606349 | HIV-1 Tat protein induces PD-L1 (B7-H1) expression on dendritic cells through tumor necrosis factor alpha- and toll-like receptor 4-mediated mechanisms |
| Q35000687 | HIV-1 Tat protein induces the production of IDO in human monocyte derived-dendritic cells through a direct mechanism: effect on T cells proliferation. |
| Q37313544 | HIV-1 Tat protein perturbs diacylglycerol production at the plasma membrane of neurosecretory cells during exocytosis |
| Q30436450 | HIV-1 Tat protein suppresses cholangiocyte toll-like receptor 4 expression and defense against Cryptosporidium parvum |
| Q46437339 | HIV-1 Tat protein-induced alterations of ZO-1 expression are mediated by redox-regulated ERK 1/2 activation |
| Q46830857 | HIV-1 Tat raises an adjuvant-free humoral immune response controlled by its core region and its ability to form cysteine-mediated oligomers |
| Q34903986 | HIV-1 Tat upregulates expression of histone deacetylase-2 (HDAC2) in human neurons: implication for HIV-associated neurocognitive disorder (HAND). |
| Q24556641 | HIV-1 Tat, apoptosis and the mitochondria: a tubulin link? |
| Q30638542 | HIV-1 Tat-induced changes in synaptically-driven network activity adapt during prolonged exposure |
| Q36185385 | HIV-1 Tat-induced microglial activation and neuronal damage is inhibited via CD45 modulation: A potential new treatment target for HAND. |
| Q33393202 | HIV-1 Tat-induced platelet activation and release of CD154 contribute to HIV-1-associated autoimmune thrombocytopenia |
| Q90221085 | HIV-1 Tat: Role in Bystander Toxicity |
| Q33581852 | HIV-1 clade B Tat, but not clade C Tat, increases X4 HIV-1 entry into resting but not activated CD4+ T cells |
| Q33641330 | HIV-1 inhibits autophagy in bystander macrophage/monocytic cells through Src-Akt and STAT3. |
| Q42229248 | HIV-1 protein Tat produces biphasic changes in NMDA-evoked increases in intracellular Ca2+ concentration via activation of Src kinase and nitric oxide signaling pathways |
| Q92205468 | HIV-1 proteins gp120 and tat induce the epithelial-mesenchymal transition in oral and genital mucosal epithelial cells |
| Q34768563 | HIV-1 regulatory proteins: targets for novel drug development |
| Q34477471 | HIV-1 tat promotes integrin-mediated HIV transmission to dendritic cells by binding Env spikes and competes neutralization by anti-HIV antibodies |
| Q40551410 | HIV-1 tat protein recruits CIS to the cytoplasmic tail of CD127 to induce receptor ubiquitination and proteasomal degradation |
| Q36040759 | HIV-1, reactive oxygen species, and vascular complications |
| Q39515527 | HIV-1-induced alterations of claudin-5 expression at the blood-brain barrier level |
| Q82182169 | HIV-TAT protein upregulates expression of multidrug resistance protein 1 in the blood-brain barrier |
| Q41578290 | HIV-Tat Protein Forms Phosphoinositide-dependent Membrane Pores Implicated in Unconventional Protein Secretion |
| Q37257571 | HIV-associated disruption of mucosal epithelium facilitates paracellular penetration by human papillomavirus |
| Q35106306 | HIV-associated disruption of tight and adherens junctions of oral epithelial cells facilitates HSV-1 infection and spread |
| Q40142273 | Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of human immunodeficiency virus type 1 Tat and gp120 proteins |
| Q33797753 | High-performance capillary electrophoresis for determining HIV-1 Tat protein in neurons |
| Q45382212 | Homeostatic chemokines CCL19 and CCL21 promote inflammation in human immunodeficiency virus-infected patients with ongoing viral replication |
| Q27637986 | Homonuclear (1)H-NMR assignment and structural characterization of human immunodeficiency virus type 1 Tat Mal protein |
| Q59353651 | Human Immunodeficiency Virus Type 1 gp120 and Tat Induce Mitochondrial Fragmentation and Incomplete Mitophagy in Human Neurons |
| Q58766255 | Human immunodeficiency virus Tat-TIP30 interaction promotes metastasis by enhancing the nuclear translocation of Snail in lung cancer cell lines |
| Q40462487 | Human immunodeficiency virus protein Tat induces oligodendrocyte injury by enhancing outward K+ current conducted by KV1.3. |
| Q44775961 | Human immunodeficiency virus type 1 Tat and methamphetamine affect the release and activation of matrix-degrading proteinases |
| Q38331655 | Human immunodeficiency virus type 1 Tat protein induces an intracellular calcium increase in human monocytes that requires DHP receptors: involvement in TNF-alpha production |
| Q36203752 | Human immunodeficiency virus type 1 genetic diversity in the nervous system: evolutionary epiphenomenon or disease determinant? |
| Q35857699 | Human immunodeficiency virus type 1 subtype C Tat fails to induce intracellular calcium flux and induces reduced tumor necrosis factor production from monocytes |
| Q34234127 | Human immunodeficiency virus type-1 and chemokines: beyond competition for common cellular receptors |
| Q36148402 | Human immunodeficiency virus type-1 protein Tat induces tumor necrosis factor-alpha-mediated neurotoxicity |
| Q30497248 | Human immunodeficiency virus-1 Tat activates calpain proteases via the ryanodine receptor to enhance surface dopamine transporter levels and increase transporter-specific uptake and Vmax. |
| Q36754429 | Human immunodeficiency virus-1 protein Tat induces excitotoxic loss of presynaptic terminals in hippocampal cultures |
| Q37194615 | Human immunodeficiency virus-associated disruption of mucosal barriers and its role in HIV transmission and pathogenesis of HIV/AIDS disease |
| Q35208314 | IL-7 receptor recovery on CD8 T-cells isolated from HIV+ patients is inhibited by the HIV Tat protein |
| Q34988973 | Ibudilast (AV411), and its AV1013 analog, reduce HIV-1 replication and neuronal death induced by HIV-1 and morphine |
| Q33873538 | Ibudilast, a pharmacologic phosphodiesterase inhibitor, prevents human immunodeficiency virus-1 Tat-mediated activation of microglial cells |
| Q81034939 | Increasing the humoral immunogenic properties of the HIV-1 Tat protein using a ligand-stabilizing strategy |
| Q24305565 | Induction of C chemokine XCL1 (lymphotactin/single C motif-1 alpha/activation-induced, T cell-derived and chemokine-related cytokine) expression by HIV-1 Tat protein |
| Q39128871 | Infection by CXCR4-Tropic Human Immunodeficiency Virus Type 1 Is Inhibited by the Cationic Cell-Penetrating Peptide Derived from HIV-1 Tat. |
| Q41419929 | Inhibition of connexin hemichannels alleviates non-alcoholic steatohepatitis in mice |
| Q37273867 | Insight into the mechanisms of aminoglycoside derivatives interaction with HIV-1 entry steps and viral gene transcription |
| Q34170914 | Intact lipid rafts regulate HIV-1 Tat protein-induced activation of the Rho signaling and upregulation of P-glycoprotein in brain endothelial cells |
| Q21245111 | Interaction of human dipeptidyl peptidase IV and human immunodeficiency virus type-1 transcription transactivator in Sf9 cells |
| Q42972738 | Interactive role of human immunodeficiency virus type 1 (HIV-1) clade-specific Tat protein and cocaine in blood-brain barrier dysfunction: implications for HIV-1-associated neurocognitive disorder |
| Q41925734 | Intracellular HIV-1 Tat protein represses constitutive LMP2 transcription increasing proteasome activity by interfering with the binding of IRF-1 to STAT1. |
| Q38310502 | Intracellular HIV-Tat expression induces IL-10 synthesis by the CREB-1 transcription factor through Ser133 phosphorylation and its regulation by the ERK1/2 MAPK in human monocytic cells. |
| Q35220407 | Investigating the role of ankyrin-rich membrane spanning protein in human immunodeficiency virus type-1 Tat-induced microglia activation |
| Q28239006 | JM4 is a four-transmembrane protein binding to the CCR5 receptor |
| Q36166231 | Ketone bodies protection against HIV-1 Tat-induced neurotoxicity |
| Q40537332 | Local delivery of recombinant vaccinia virus expressing secondary lymphoid chemokine (SLC) results in a CD4 T-cell dependent antitumor response |
| Q40056807 | Lytic EBV infection investigated by detection of Soluble Epstein-Barr virus ZEBRA in the serum of patients with PTLD. |
| Q37728093 | Macrophage signaling in HIV-1 infection |
| Q39834242 | Mechanism for HIV-1 Tat insertion into the endosome membrane |
| Q33770575 | Mechanism of HIV-1-TAT induction of interleukin-1beta from human monocytes: Involvement of the phospholipase C/protein kinase C signaling cascade |
| Q34516015 | Mesenchymal stem cell derived hematopoietic cells are permissive to HIV-1 infection |
| Q36950000 | Mitogen-activated protein kinase p38 in HIV infection and associated brain injury |
| Q35921136 | Modeling HIV-associated neurocognitive disorders in mice: new approaches in the changing face of HIV neuropathogenesis |
| Q33889326 | Modifications in host cell cytoskeleton structure and function mediated by intracellular HIV-1 Tat protein are greatly dependent on the second coding exon |
| Q40903523 | Modulation of microtubule assembly by the HIV-1 Tat protein is strongly dependent on zinc binding to Tat. |
| Q37501478 | Molecular mechanism: the human dopamine transporter histidine 547 regulates basal and HIV-1 Tat protein-inhibited dopamine transport |
| Q36157637 | Morphine modulation of toll-like receptors in microglial cells potentiates neuropathogenesis in a HIV-1 model of coinfection with pneumococcal pneumoniae |
| Q34343025 | Mutation of tyrosine 470 of human dopamine transporter is critical for HIV-1 Tat-induced inhibition of dopamine transport and transporter conformational transitions. |
| Q41863627 | Neuronal survival and resistance to HIV-1 Tat toxicity in the primary culture of rat fetal neurons. |
| Q35749130 | Neuropathologies in Transgenic Mice Expressing Human Immunodeficiency Virus Type 1 Tat Protein under the Regulation of the Astrocyte-Specific Glial Fibrillary Acidic Protein Promoter and Doxycycline |
| Q38815332 | New paradigms in chemokine receptor signal transduction: Moving beyond the two-site model. |
| Q36710889 | Nonmuscle myosin light-chain kinase mediates microglial migration induced by HIV Tat: involvement of β1 integrins. |
| Q34691351 | Novel multi-component nanopharmaceuticals derived from poly(ethylene) glycol, retro-inverso-Tat nonapeptide and saquinavir demonstrate combined anti-HIV effects |
| Q37547409 | Novel neuroprotective GSK-3β inhibitor restricts Tat-mediated HIV-1 replication |
| Q38344102 | Nox4-derived H2O2 mediates endoplasmic reticulum signaling through local Ras activation |
| Q33649838 | Nuclear factor-kappa B family member RelB inhibits human immunodeficiency virus-1 Tat-induced tumor necrosis factor-alpha production |
| Q35941437 | Oligodendrocytes Are Targets of HIV-1 Tat: NMDA and AMPA Receptor-Mediated Effects on Survival and Development. |
| Q37002797 | PPARalpha and PPARgamma effectively protect against HIV-induced inflammatory responses in brain endothelial cells |
| Q40508633 | Phosphatidylinositol-(4,5)-bisphosphate enables efficient secretion of HIV-1 Tat by infected T-cells |
| Q34281340 | Platelet-derived growth factor-BB restores HIV Tat -mediated impairment of neurogenesis: role of GSK-3β/β-catenin. |
| Q35009483 | Preferential vulnerability of astroglia and glial precursors to combined opioid and HIV-1 Tat exposure in vitro. |
| Q79869481 | Preventing HIV-1 Tat-induced neuronal apoptosis using antioxidant enzymes: mechanistic and therapeutic implications |
| Q24799564 | Proliferative activity of extracellular HIV-1 Tat protein in human epithelial cells: expression profile of pathogenetically relevant genes |
| Q36253322 | Proteoglycans in host-pathogen interactions: molecular mechanisms and therapeutic implications |
| Q26853681 | Proteomics, biomarkers, and HIV-1: A current perspective |
| Q40852719 | Protocol for Detection of HIV-Tat Protein in Cerebrospinal Fluid by a Sandwich Enzyme-Linked Immunosorbent Assay |
| Q55315288 | Reduced intraepidermal nerve fibre density, glial activation, and sensory changes in HIV type-1 Tat-expressing female mice: involvement of Tat during early stages of HIV-associated painful sensory neuropathy. |
| Q33605370 | Repeated cocaine treatment enhances HIV-1 Tat-induced cortical excitability via over-activation of L-type calcium channels |
| Q34378293 | RhoA/Rho-kinase and vascular diseases: what is the link? |
| Q37519397 | Role of Tat protein in HIV neuropathogenesis |
| Q36045347 | Role of endolysosomes in HIV-1 Tat-induced neurotoxicity |
| Q26996314 | Roles and functions of HIV-1 Tat protein in the CNS: an overview |
| Q34645645 | Selection in context: patterns of natural selection in the glycoprotein 120 region of human immunodeficiency virus 1 within infected individuals |
| Q39023036 | Selective up-regulation of functional CXCR4 expression in erythroid cells by HIV-1 Tat protein |
| Q48939388 | Signaling mechanisms of HIV-1 Tat-induced alterations of claudin-5 expression in brain endothelial cells |
| Q33640033 | Similarity in viral and host promoters couples viral reactivation with host cell migration |
| Q39797374 | Single particle tracking confirms that multivalent Tat protein transduction domain-induced heparan sulfate proteoglycan cross-linkage activates Rac1 for internalization |
| Q39197203 | Small HIV-1-Tat peptides inhibit HIV replication in cultured T-cells |
| Q92912382 | Strong In Vivo Inhibition of HIV-1 Replication by Nullbasic, a Tat Mutant |
| Q40613424 | Structure-activity relationship of neomycin, paromomycin, and neamine-arginine conjugates, targeting HIV-1 gp120-CXCR4 binding step. |
| Q35613792 | T-cell and neuronal apoptosis in HIV infection: implications for therapeutic intervention |
| Q36868552 | Targeting the glutamatergic system for the treatment of HIV-associated neurocognitive disorders |
| Q34091216 | Tat 101-mediated enhancement of brain pericyte migration involves platelet-derived growth factor subunit B homodimer: implications for human immunodeficiency virus-associated neurocognitive disorders. |
| Q28214887 | Tat acetyl-acceptor lysines are important for human immunodeficiency virus type-1 replication |
| Q38877236 | Tat mutations in an African cohort that do not prevent transactivation but change its immunogenic properties |
| Q22248066 | The C Terminus of HIV-1 Tat Modulates the Extent of CD178-mediated Apoptosis of T Cells |
| Q97525253 | The Glutamate System as a Crucial Regulator of CNS Toxicity and Survival of HIV Reservoirs |
| Q22248069 | The Glutamine-rich Region of the HIV-1 Tat Protein Is Involved in T-cell Apoptosis |
| Q40369884 | The HIV-1 Tat protein selectively enhances CXCR4 and inhibits CCR5 expression in megakaryocytic K562 cells |
| Q28085435 | The Startling Properties of Fibroblast Growth Factor 2: How to Exit Mammalian Cells without a Signal Peptide at Hand |
| Q40213471 | The ability of chloroquine to prevent tat-induced cytokine secretion by monocytes is implicated in its in vivo anti-human immunodeficiency virus type 1 activity. |
| Q33974601 | The basic domain of HIV-tat transactivating protein is essential for its targeting to lipid rafts and regulating fibroblast growth factor-2 signaling in podocytes isolated from children with HIV-1-associated nephropathy |
| Q26777952 | The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disorders |
| Q35689260 | The human immunodeficiency virus type 1 tat protein enhances Cryptosporidium parvum-induced apoptosis in cholangiocytes via a Fas ligand-dependent mechanism |
| Q38292349 | The human immunodeficiency virus-1 Tat protein activates human umbilical vein endothelial cell E-selectin expression via an NF-kappa B-dependent mechanism |
| Q48485626 | The immunophilin ligand GPI1046 protects neurons from the lethal effects of the HIV-1 proteins gp120 and Tat by modulating endoplasmic reticulum calcium load |
| Q34219706 | The ins and outs of HIV-1 Tat. |
| Q35917148 | The next generation of HIV/AIDS drugs: novel and developmental antiHIV drugs and targets |
| Q35047224 | The oral commensal, Streptococcus gordonii, synergizes with Tat protein to induce HIV-1 promoter activation in monocytes/macrophages |
| Q40833190 | The possible involvement of CXCR4 in the inhibition of HIV-1 infection mediated by DP178/gp41. |
| Q41922188 | The role of human dopamine transporter in NeuroAIDS. |
| Q37876485 | The unconventional secretory machinery of fibroblast growth factor 2. |
| Q33734695 | Time-Dependent, HIV-Tat-Induced Perturbation of Human Neurons In Vitro: Towards a Model for the Molecular Pathology of HIV-Associated Neurocognitive Disorders |
| Q37825906 | Tits and bits of HIV Tat protein. |
| Q35024694 | Transactivation and signaling functions of Tat are not correlated: biological and immunological characterization of HIV-1 subtype-C Tat protein |
| Q33933260 | Viral exploitation and subversion of the immune system through chemokine mimicry |
| Q37220038 | What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine? |
| Q54415847 | [HIV-associated cognitive disorders: tat perturbs neurosecretion]. |
Search more.